ARCHIVES

California Weighs Listing Tamoxifen As Carcinogen

This article is from The Cancer Letter archive.

Vol. 21 No. 41 | October 27, 1995

Download PDF Visit The Full Archive

Related Articles

Clinton R&D Budget Amounts to a Cut, AAAS Study Says

April 18, 1997

Clinical Instigator Object To HEW Proposal On Compensation Notification In Consent Forms

December 15, 1978

NCI Advisors Reject $30-Million Cohort Study, Approve Renewal of Phase I Clinical Trials Initiatives and American College of Radiology Imaging Network.

July 7, 2006

Proof of principle needed before launching “big science” program, advisors say.

March 11, 2005

FDA Approves Manufacturer Of IVAX Paclitaxel Ingredient.

June 29, 2001

NCI’s Justification For 1981 Budget

June 8, 1979